Support of American Heart Association Encourages Customers to Know Their Numbers DEERFIELD, Ill., February 03, 2014 – In support of American Heart Month, Walgreens (NYSE: WAG) (Nasdaq: WAG) is offering free blood pressure testing at all of its pharmacies and Healthcare Clinic* at select Walgreens locations throughout the month of February. Tests are available daily […]
Walgreens exclusive agreement with Vitamin Angels includes donation of 1 percent of retail sales from vitamin purchases of participating brands DEERFIELD, Ill., June 05, 2014 – As part of its purpose to help people get, stay and live well, Walgreens (NYSE: WAG) (NASDAQ: WAG) is extending its exclusive1 relationship with Vitamin Angels to help provide […]
In U.S., company distributes $10 million worth of flu shot vouchers in collaboration with U.S. Department of Health and Human Services DEERFIELD, Ill., January 15, 2014 – Walgreens (NYSE: WAG) (Nasdaq: WAG) today announced it is donating the value of three million life-saving vaccines for children in developing countries, upon successful completion of its immunizations […]
WOONSOCKET, R.I., Jan. 13, 2015 /PRNewswire/ –A new analysis by researchers at Brigham and Women’s Hospital and the CVS Health (NYSE: CVS) Research Institute, published on-line first in the American Journal of Public Health, shows that enhanced prescription drug insurance can improve patient health outcomes and reduce use of other, often costly, health care services. […]
Dr. Abigail Doyle (Associate Professor at Princeton University, USA) wins the „Chemistry“ category / Dr. Steven Spoel (Principal Investigator at the University of Edinburgh, UK) takes the „Biology“ award /Dr. Javier Fernandez (Associate Researcher at Wyss Institute/Harvard University, Boston, USA) awarded prize in the „Materials“ field Leverkusen, January 10, 2013 – The winners of the Bayer […]
Cambridge, Mass and Richmond, Calif. – January 9, 2014 – Biogen Idec (NASDAQ:BIIB) and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin. The agreement will enable Biogen Idec to further enhance its […]
Special global web conference “One Health” to address zoonotic disease within the veterinary and public health fields Leverkusen, January 9, 2014 – Nearly half of the world’s population is infected with at least one type of vector-borne disease (1). These diseases are transmitted from parasites to animals and humans, and have a significant impact on public health […]
Pathway to Stop Diabetes will provide funding for innovative diabetes researchers Alexandria, VA (January 9, 2014) – With nearly 26 million adults and children in the U.S. living with diabetes, and another 79 million living with prediabetes, diabetes is a physical and financial burden for the health of the nation. To accelerate the research needed […]
NEW YORK, Jan. 9, 2014 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT) (Intercept) today announced that the FLINT trial of obeticholic acid (OCA) for the treatment of nonalcoholic steatohepatitis (NASH) has been stopped early for efficacy based on a planned interim analysis showing that the primary endpoint of the trial has been met. FLINT is a multi-center, double-blind, placebo-controlled […]
RICHMOND, Calif., Jan. 8, 2014 /PRNewswire/ — Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo’s president and chief executive officer, will present an update on Sangamo’s clinical and preclinical ZFP Therapeutic® programs and upcoming milestones, as well as an overview of the Company’s business strategy at the 32ND AnnualJ.P. Morgan Healthcare Conference on Thursday, January 16TH at 11:00 am PT in San Francisco. “Sangamo […]